ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

November 5, 2010

In Brief: Broder Invokes Cancer Act Provision To Inform Hammer, Bush Of Potential Damage Of 32% Cut

September 7, 1990

Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.

March 5, 2004

Senate Confirms McClellan For FDA

October 25, 2002

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999